Twiist Postmarket Surveillance Study for Type 1 Diabetes

计划入组 1,875 人 · 首次发布于 2026 年 1 月 21 日

Innovative Automated Insulin Delivery System for Type 2 Diabetes

计划入组 307 人 · 首次发布于 2025 年 3 月 3 日

Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

计划入组 32 人 · 首次发布于 2026 年 9 月 8 日

MIIST-305

anti-DKK1 antibodies(Twist Bioscience)

anti-CD40 agonistic antibodies(Twist Bioscience)

SWIISH PTY LTD

Australia

TWIICE NEW ZEALAND LIMITED

New Zealand

FDA Clears Sequel's twiist AID System, First Insulin Pump to Directly Measure Every Micro-Dose

Senseonics Launches First Commercial Integration of One-Year CGM with Automated Insulin Delivery System

Breakthrough in Diabetes Management: First One-Year CGM System Integrates with Automated Insulin Delivery